DOAK als «new normal» bei Vorhofflimmern und venösen Thromboembolien
Thrombosis and Stroke
SPECIAL REPORT
Related content
Atrial Fibrillation
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis
J Am Coll Cardiol
Pabon MA, Filippatos G, Claggett BL, Miao MZ, Desai AS, Jhund PS, Henderson A, Brinker M, Schloemer P, Hofmeister L, Li L, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD, Vaduganathan M
doi: 10.1016/j.jacc.2025.03.429
Heart, Artery and Coronary Diseases
Risk of coronary artery disease in intermediate hyperglycemia and type 2 diabetes defined by 1-hour post-load glucose levels according to the new IDF criteria
Diabetes Res Clin Pract
Vanessa Fiorentino T, Maria Assunta Cefalo C, Rubino M, Riccio A, Succurro E, Cassano V, Chiara Mannino G, Perticone M, Sciacqua A, Andreozzi F, Sesti G
doi: 10.1016/j.diabres.2026.113100
Heart Failure
Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF Trial
JACC Heart Fail
Ostrominski JW, Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Borentian M, Rohwedder K, Lay-Flurrie J, Lavagnino MA, McMurray JJV, Solomon SD
doi: 10.1016/j.jchf.2025.03.007
Atrial FibrillationMyocardial Infarction
New-Onset Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow-Up
J Am Heart Assoc
Demidova MM, Baturova MA, Erlinge D, Platonov PG
doi: 10.1161/JAHA.124.040478
COMMENTED
Cardiovascular Risk and Diseases
Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Vazquez Arreola E, Gong Q, Hanson RL, Wang J, Sandforth L, He S, Sandforth A, Qian X, Giacca M, Bornstein SR, Fritsche A, Stefan N, Preissl H, Gregg EW, Marx N, Jumpertz-von Schwartzenberg R, Li G, Birkenfeld AL
doi: 10.1016/S2213-8587(25)00295-5
Cardiovascular Risk and Diseases
Peripartum cardiomyopathy
Lancet
Sliwa K, Hilfiker-Kleiner D, Damasceno A, Al Farhan H, Goland S, Johnson MR, Bauersachs J
doi: 10.1016/S0140-6736(25)01451-5
Atrial Fibrillation
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin
Circulation
Al Said S, Braunwald E, Palazzolo MG, Melloni GEM, Geller BJ, Ruff CT, Antman EM, Carnicelli AP, Eikelboom J, Granger CB, Patel MR, Wallentin L, Giugliano RP
doi: 10.1161/CIRCULATIONAHA.125.075275
Heart, Artery and Coronary Diseases
How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO Registry
Am Heart J
Baldi C, Maio MD, Esposito L, Bellino M, Silverio A, Adamo M, Rubbio AP, De Felice F, Giordano A, Grasso C, Denti P, Godino C, De Marco F, Castriota F, Monteforte I, Mongiardo A, Petronio AS, Crimi G, Villa E, Bartorelli AL, Citro R, Galasso G, Tarantini G, Tamburino C, Bedogni F, GIOTTO registry
doi: 10.1016/j.ahj.2025.01.013
Heart Failure
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
JAMA Cardiol
Ruberg FL, Teruya S, Helmke S, Smiley DA, Fine D, Kurian D, Raiszadeh F, Prokaeva T, Spencer B, Wong S, Pandey S, Blaner WS, DeLuca A, Johnson LL, Kinkhabwala MP, Leb J, Mintz A, LaValley MP, Einstein AJ, Cohn E, Gallegos C, Murtagh G, Kelly JW, Miller EJ, Maurer MS
doi: 10.1001/jamacardio.2025.2948